[Form 4] Chemours Co Insider Trading Activity

Chemours Co Chief Accounting Officer David Will reported an equity award and a related tax withholding transaction.

Rhea-AI Filing Summary

Chemours Co Chief Accounting Officer David Will reported an equity award and a related tax withholding transaction. He received a grant covering 8,337 shares of common stock at no cost, structured as an RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027. In a separate transaction, 699 shares were automatically withheld at $18.24 per share to satisfy tax obligations on vesting restricted stock units and dividend equivalent units; the footnote states that no shares were sold in the market. Following these transactions, his directly owned holdings, including RSUs and dividend equivalent units, total 33,083.5415 shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Will David

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,337	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	699	$18.24	$13K

Holdings After Transaction: Common Stock — 33,083.5415 shares (Direct)

Footnotes (3)

1. F1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
2. F2. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.
3. F3. Includes directly owned shares, RSUs and dividend equivalent units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Chemours (CC) Chief Accounting Officer David Will report?

David Will reported receiving a stock-based award covering 8,337 Chemours common shares at no cost, plus a separate transaction where 699 shares were automatically withheld to cover tax obligations on vesting restricted stock units and dividend equivalent units.

How many Chemours (CC) shares were granted to David Will in this Form 4?

David Will was granted an equity award tied to 8,337 shares of Chemours common stock at a price of $0.00 per share. A footnote explains this is an RSU award that vests in three equal annual installments starting on March 1, 2027.

Why were 699 Chemours (CC) shares disposed of in David Will’s Form 4?

The Form 4 shows 699 shares disposed of at $18.24 per share, but the footnote clarifies they were automatically withheld to satisfy tax obligations on vesting RSUs and dividend equivalent units. It explicitly states that no shares were sold in the market.

When will David Will’s Chemours (CC) RSU award reported on Form 4 vest?

The footnotes state that the RSU award tied to 8,337 shares is scheduled to vest in three equal annual installments, beginning on March 1, 2027. Each year, one-third of the award is expected to vest under that schedule.

How many Chemours (CC) shares and units does David Will hold after these transactions?

After the reported transactions, David Will’s direct holdings total 33,083.5415 Chemours-related units. A footnote explains this figure includes directly owned shares, restricted stock units (RSUs), and dividend equivalent units, rather than only currently tradable common shares.

Does David Will’s Form 4 show an open-market sale of Chemours (CC) stock?

The Form 4 does not show an open-market sale. While 699 shares are reported as disposed, the footnote specifies they were withheld to cover tax obligations on vesting RSUs and dividend equivalent units, and that no shares were sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:59 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Will David

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19899

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		699(1)	D	$18.24	24,746.5415	D
Common Stock	03/02/2026		A		8,337(2)	A	$0	33,083.5415(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

2. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.

3. Includes directly owned shares, RSUs and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.